Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-23-011781
Filing Date
2023-04-26
Accepted
2023-04-26 19:34:34
Documents
1
Period of Report
2022-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 7504
  Complete submission text file 0000899243-23-011781.txt   8817
Mailing Address 88 SIDNEY ST CAMBRIDGE MA 021394136
Business Address
FRATES JAMES M (Reporting) CIK: 0001235598 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41199 | Film No.: 23851340

Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Issuer) CIK: 0001658551 (see all company filings)

EIN.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations